Results 1 to 10 of about 2,200,859 (305)
A framework for nationwide COVID-19 vaccine safety research in the Republic of Korea: the COVID-19 Vaccine Safety Research Committee [PDF]
Osong Public Health and Research Perspectives, 2023 With the introduction of coronavirus disease 2019 (COVID-19) vaccines, the Korea Disease Control and Prevention Agency (KDCA) commissioned the National Academy of Medicine of Korea to gather experts to independently assess post-vaccination adverse events.
Na-Young Jeong +10 more
doaj +1 more source
Long COVID occurrence in COVID-19 survivors [PDF]
Scientific Reports, 2022 Abstract This cross-sectional study aimed to investigate the post-acute consequences of COVID-19. We conducted a self-administered questionnaire survey on sequelae, psychological distress (K6), impairments in work performance (WFun), and COVID-19–related experiences of stigma and discrimination in two designated COVID-19 hospitals in ...
Aya Sugiyama +14 more
openaire +3 more sources
Revista Argentina de Reumatología, 2022 Introducción: el lupus eritematoso sistémico (LES) es una enfermedad sistémica que se ha asociado a mayor severidad con la infección por SARS-CoV-2. Particularmente la alta actividad de la enfermedad y algunos inmunosupresores se han vinculado a peores ...
Carolina Ayelén Isnardi +34 more
doaj +1 more source
Long COVID and chronic COVID syndromes [PDF]
Journal of Medical Virology, 2020 We thank Dr Garg and colleagues for their interest in our work and their useful comments.1 We agree that our cohort of hospitalised patients is correspondingly older, more likely to have had severe disease and have more comorbidities than groups whose primary COVID-19 infection was mild and managed in the community.
Halpin, Stephen +2 more
openaire +4 more sources
Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant
Communications Medicine, 2021 Coutinho et al. use genomic and epidemiological data from Manaus, Brazil, to estimate the transmissibility and potential for reinfection with the SARS-CoV-2 variant-of-concern P.1 (gamma).
Renato Mendes Coutinho +14 more
doaj +1 more source
The World Health Organization COVID-19 surveillance database
International Journal for Equity in Health, 2022 In January 2020, SARS-CoV-2 virus was identified as a cause of an outbreak in China. The disease quickly spread worldwide, and the World Health Organization (WHO) declared the pandemic in March 2020. From the first notifications of spread of the disease,
Maya Allan +10 more
doaj +1 more source
BMC Infectious Diseases, 2023 Background University students commonly received COVID-19 vaccinations before returning to U.S. campuses in the Fall of 2021. Given likely immunologic variation among students based on differences in type of primary series and/or booster dose vaccine ...
Peter M. DeJonge +24 more
doaj +1 more source
A cohort study measuring SARS-CoV-2 seroconversion and serial viral testing in university students
BMC Infectious Diseases, 2022 Background To improve understanding of the antibody response to SARS-CoV-2 infection, we examined seroprevalence, incidence of infection, and seroconversion among a cohort of young adults living on university campuses during the fall of 2020.
Christine C. Lee +23 more
doaj +1 more source
Countries with delayed COVID-19 introduction – characteristics, drivers, gaps, and opportunities
Globalization and Health, 2021 Background Three months after the first reported cases, COVID-19 had spread to nearly 90% of World Health Organization (WHO) member states and only 24 countries had not reported cases as of 30 March 2020. This analysis aimed to 1) assess characteristics,
Zheng Li +11 more
doaj +1 more source
Diabetology, 2022 The research is based on a clinical observation of the neurological and neuro-cognitive status of 300 patients, belonging to the Partinico Hospital and the Post-Long Covid clinic, which had contracted the SARS-CoV-2 virus in the period between April 2021
Concetta Mezzatesta +6 more
doaj +1 more source